Filing Details

Accession Number:
0001156039-21-000038
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-23 16:31:14
Reporting Period:
2021-03-22
Accepted Time:
2021-03-23 16:31:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1156039 Anthem Inc. ANTM Hospital & Medical Service Plans (6324) 352145715
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1608538 D Peter Haytaian 220 Virginia Avenue
Indianapolis IN 46204
Evp & President, Commercial No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-22 15,593 $146.93 59,544 No 4 M Direct
Common Stock Acquisiton 2021-03-22 22,500 $131.80 82,044 No 4 M Direct
Common Stock Disposition 2021-03-22 300 $345.59 81,744 No 4 S Direct
Common Stock Disposition 2021-03-22 9,387 $347.44 72,357 No 4 S Direct
Common Stock Disposition 2021-03-22 12,416 $348.52 59,941 No 4 S Direct
Common Stock Disposition 2021-03-22 26,777 $349.53 33,164 No 4 S Direct
Common Stock Disposition 2021-03-22 7,891 $350.21 25,273 No 4 S Direct
Common Stock Disposition 2021-03-22 400 $351.32 24,873 No 4 S Direct
Common Stock Disposition 2021-03-22 2,329 $352.84 22,544 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2021-03-22 15,593 $0.00 15,593 $146.93
Common Stock Employee Stock Option (Right to Buy) Disposition 2021-03-22 22,500 $0.00 22,500 $131.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-03-02 No 4 M Direct
1,848 2026-03-01 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February, 1, 2021.
  2. This transaction was executed in multiple trades at prices ranging from $345.53 to $345.66. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $346.93 to $347.91. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $347.95 to $348.91. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. This transaction was executed in multiple trades at prices ranging from $348.97 to $349.94. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  6. This transaction was executed in multiple trades at prices ranging from $349.97 to $350.72. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  7. This transaction was executed in multiple trades at prices ranging from $350.99 to $351.54. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  8. The option represents a right to purchase a total of 22,353 shares and is exercisable in six semi-annual installments, with three installments of 3,725 shares each and three installments of 3,726 shares each beginning on September 2, 2015, which is the six-month anniversary of the date on which the option was granted
  9. The option represents a right to purchase a total of 24,348 shares, and is exercisable in six semi-annual installments of 4,058 shares each, beginning on September 1, 2016, which is the six-month anniversary of the option grant date.